[
    "-",
    "-",
    "-",
    "-",
    "1",
    "A stock solution was made by mixing Ni(OAC) with (S), S)-Ph-BPE in a 1.1.1 molar ratio inCF3CH2OH and stirred at room temperature for 4-5 h until forming homogeneous yellow solutionin a argon-filled glovebox. An aliquot of the catalyst solution (0.2 mL, 0.001 mmol) wastransferred by syringe into the vial charged with substrate la (1.0 mmol) in CF3 CH2OH (08 mL).",
    "Chrome S2 By NMR Sermon of Sonzar 1.2. reaped to Taba 3.",
    "Chrome Slabs HRLC Specimen of creme-A-Bore-a-bore-b-bene-bened to Scheme!",
    "Empire S&B. C.C. spectrum of lacemc-4.1, created to table 3.",
    "Empres S2. H1NMR spectrum of sonarize In lead to Sinee 2",
    "Empres S8 (C-NRK spectrum to sonarize in lead to Nome 2)",
    "Figure 1. The Structure of Chiral Diaphosphine Lignals",
    "Figure 5.0 HPL C spectrum of laceme-2h, alexedo to table 3.",
    "Figure 564, HPL C spectrum of laceme-2d, alexedo to table 3",
    "Figure 5th SBH HPLC spectrum of 2a (Crystalization), related to Scheme 3.",
    "Figure S.S. HPLC spectrum of 2.1 related to Table 3.",
    "Figure S/2. HPL C spectrom of raceme-2h, alexedo to table 3.",
    "Figure S/6 HPC C spectrum of lacemc-2, fixed to table 3",
    "Figure S1. IH NMR spectrum of 2k released to Table 3.",
    "Figure S1.0. HPL C spectrum of raceme-2g, realeed to table 3.",
    "Figure S1.1 HPLC spectrum of 2g related to Table 3",
    "Figure S100, HPLC spectrum of 4, released to Scheme 4.",
    "Figure S102 HPLC spectrum of 5, released to Scheme 4",
    "Figure S10A, HPLC Specimen of M-Bsc-a, Bsc-b, e-related to Scheme 4.",
    "Figure S2. HPL C spectrum of lacemc-2c released to Table 3",
    "Figure S2. HPLC Spectrum of 2x related to Table 3",
    "Figure S2. HPLC spectrum of laceme-2.2, related to Scheme 2",
    "Figure S2. If NMR spectrom of 2, if related to Table 3",
    "Figure S3. HPLC spectrum of 2h related to Table 3",
    "Figure S4, HPL C spectrum of raceme-2, fixed to table 3",
    "Figure S6b. HFL C spectrum of raceme-2c. realeed to table 3.",
    "Figure S6l IPC C spectrum of 2b, related to Table 3",
    "Figure S6s. HPC C spectrum of 2d, related to Table 3.",
    "Figure S7Z. HPC C spectrum of 2i, related to Table 3",
    "Figure S8 X8 HPL C spectrum of raceme-2k realeed to table 3",
    "Figure S82 HPL C spectrom of raceme-2m reended to Table 3",
    "Figure S89 HPLC spectrum of 2f related to Table 3",
    "Figure S89. GC spectrum of 2p, 2n related to Table 3",
    "Figure S8B, HPL C spectrum of raceme-2, extended to Table 3",
    "Figure S8L HPC C spectrum of 2.1 related to Table 3",
    "Figure S8L, HPL C spectrum of raceme-2.2, an extended to table 3.",
    "Figure S8S8 HPC C spectrum of lacemc-2, fixed to table 3",
    "Figure S8V. GC spectrum of 2.0 related to Table 3.",
    "Figure S8s. HPC C spectrum of 2c related to Table 3.",
    "Figure S8s. IPC C spectrum of 2m reflected to Table 3",
    "Figure S8s. IPC C spectrum of 2n related to Table 3.",
    "Figure S9.1. HPL C spectrum of lacemc's 3 related to Scheme 4.",
    "Figure S9.99 JPG PLC spectrum of lacemc-4, an extended to Scheme 2",
    "Figure S91 HPLC spectrum of 2a, released to Scheme 2",
    "Figure S94, HLLC spectrum of laceme-2a, extended to Scheme 3.",
    "Figure S95. HPLC spectrum of 2a, related to Scheme 3.",
    "Figure S98. HPLC spectrum of 3, replaced to Scheme 4.",
    "Figure S99, HPL C spectrum of lacrimo or lacrimc-4, related to Scheme 4.",
    "Figure S9S. HPLC spectrum of 2r related to Scheme 2",
    "Figure SS8 HPC C spectrum of raceme-2a, related to Table 3",
    "Figure SS9. HPLC spectrum of 2a, related to Table 3",
    "Figure Sbz. HPC C spectrum of 2e, related to Table 3",
    "Figure Sz. IH NMR spectrum of 2n related to Table 3",
    "Gemme S.M. (C)NMR spectromo of 2.0 released to Table 3.",
    "Gemme S.V. IH NMR spectrum of 3, released to Scheme 4.",
    "Gemme S18 Lc NMR Specimen of 2d, 1d, 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, 9th, 10th, 11th, 12th, 13th, 14th, 15th, 16th, 17th, 18th, 19th, 20th, 21st, 22nd, 23rd, 24th, 25th, 26th, 27th, 28th, 29th, 30th, 31st, 32nd, 33rd, 34th, 35th, 36th, 37th, 38th, 39th, 40th, 41st, 42nd, 43rd, 44th, 45th, 46th, 47th, 48th, 49th, 50th, 51st, 52nd, 53rd, 54th, 55th, 56th, 57th, 58th, 59th, 60th, 61st, 62nd, 63rd, 64th, 65th, 66th, 67th, 68th, 69th, 70th, 71st, 72nd, 73rd, 74th, 75th, 76th, 77th, 78th, 79th, 80th, 81st",
    "Gemme S2 1c CNMR spectrum of 2p, 2n reached to Table 3",
    "Gemme S2L 1NMR spectrum of 2.1 leaded to Table 3",
    "Gemme S2m Lr.CNMKR spectrum of 2 zelenco in table 3.",
    "Gemme S4 C.NMR spectrum of 2.4, fixed to Scheme 2",
    "Gemme S5 IN NMR spectrum of 2 z. zeneto to Sreme 2",
    "Gemme S8 by C.NMR Specimen of 3. Leaked to Screme!",
    "Gemme S8S8 C.C. Sermon of lacemc-2p. ieded to Table 3",
    "Gemme S8s Lc NMR Spermmo for 21.2h reeded in Table 3",
    "Gemme Sb. (C)NMR spectrum of sonarize In lp. ernetto table 3",
    "Gemme Sfk (C)NMR spectrum of 2c released to Table 3",
    "Gemme Siz 1/2 CMMR Spermmo for 2a realeo in Table 3",
    "Gene S.S. IH NMR Spermmo of 2m reened to Table 3",
    "Gene S.S.D. [CNMKR spectrum of 2.1 released to Table 3",
    "Gene S.S.I. (C.NMR spectrum of 1, leaded to Scheme 4)",
    "Gene S.S.I. By C.NMR spectrum of 6 ileated to Scheme 4.",
    "Gene S19. IH NRMR spectrum of a 2.2 reeded to table 3",
    "Gene S2. HNRMR spectrum of 2h released to Table 3",
    "Gene S2x 1c NMR spectrum of 21.2h extended to Table 3",
    "Gene Sis. IH NRMR spectrum of 2c released to Table 3",
    "Gene Sis. IH NRMR spectrum of 2h, released to Table 3",
    "Gene SsS3. IH NMR spectrum of 2.1 levered to Table 3",
    "Gene Sz. 1/2 cmMR Specimen of 2x leaded to table 3",
    "Gimme St. (NMR) performa de sistema de sonizare Il templo de la fala 3",
    "Gimme Sui (NMR) performa de sonzare lr. lecado lo Nuevo Nueva (2)",
    "Gome S2 2 1c NMR Spermmo of 2.1 leaded in Table 3",
    "Gome S2 Lc.NMR Spermmo for 2.2 realeo in Table 3.",
    "Home S/2 IN NRMR Spermmo of 2.2 reeden in Taba 3",
    "Home S2x For NMR Speculum of 2.1 released in Table 3.",
    "Home St. A NMR spectrum of sonnazie in ilemend to Table 3",
    "Homes S&H INMR spectrum of 2.2D (2.1D) extended to Scheme 5",
    "Homes S2: A NMR spectrum of sonnazze Ir lead to Shame 2",
    "Igne Sz. 1NMR spectrom of 21.1 reeded to table 3",
    "Impere Siz. 1NMR spectrum of 2d. 2d leaded to table 3.",
    "Ipone S9, IH NMR spectrum of 2.0 rezened to table 3",
    "Lepre S.S. A NMR spectrum of sonarze Il lezendo in Table 3",
    "Lepre S.S.h. (C)NMR specum of 2m length to table 3",
    "Lepre S6h (C.NMR Spermmo of 2r rezened to Scheme 2)",
    "Lepre S8 HNMR spectrum of A4, replaced to Scheme 2",
    "Lepres S.S. FMNR spectrum of sonarize In lp, reenact to table 3",
    "Lepres SZ. In NMR spearmo of 2-4-D. (exceed to Scheme 5)",
    "Lighe S1 M1 INMR spectrum of 2h, reeded to table 3",
    "Lighe S14. Lc NMR spectrom of 2h, 2d, 1d, 2e, 3e, 4e, 5e, 6e, 7e, 8e, 9e, 10e, 11e, 12e, 13e, 14e, 15e, 16e, 17e, 18e, 19e, 20e, 21e, 22e, 23e, 24e, 25e, 26e, 27e, 28e, 29e, 30e, 31e, 32e, 33e, 34e, 35e, 36e, 37e, 38e, 39e, 40e, 41e, 42e, 43e, 44e, 45e, 46e, 47e, 48e, 49e, 50e, 51e, 52e, 53e, 54e, 55e, 56e, 57e, 58e, 59e, 60e, 61e, 62e, 63e, 64e, 65e, 66e, 67e, 68e, 69e, 70e, 71e, 72e, 73e, 74e, 75e, 76e, 77e, 78e, 79e, 80e, 81e, 82e, 83e, 84e, 85e, 86e, 87e, 88e, 89e",
    "Lighe S2.1 Lc NMR Specimen of 2. Leaked to Table 3",
    "Lighe Sg. 1NMR spectrum of 4, leaded to Scheme 4.",
    "Ligme S1. INMR spearmot of 5, leaded to Scheme 4.",
    "Ligme S2 1c NMR spectrum of 5. leaded to Scheme 4.",
    "Ligme Ss3 In NMR spectrum of 6, leaded to Scheme 4.",
    "S",
    "SIMONA'S CAME SAVA",
    "Scheme 4 Synthetic Transformations of Product 2a",
    "Scheme 5. Deuterium-Labeling Experiments(A) The hydrogenation with D2 in CF3CH2OH.(B) The hydrogenation with H2 inCF3CH3OD.(C) The product 2a stirring in CF 3CH2OD.",
    "Scheme S7:",
    "Simplified Ligues for Hair Hair Lyrical Mark Serra at Imports 24/7",
    "Supplemental Homes for It Spectra at Centennial Lakewood Studios",
    "Synthetic transformation",
    "Table 1. Screening Ligands for Ni-Catalyzed Asymmetric Hydrogenation of 4-Phenyl-5H-1,2,3-oxathiazole2,2-dioxide (1a)NR, no reaction; NA, not available.Unless otherwise noted, all reactions were carried out with a Ni(OAc2)/ligand/substrate 1a (0.1 mmol) ratio of 1:1:1.20 in1.0 mL MeOH under 60 atm H2 at 80\u2103 for 24 h. The configuration of 2a was determined by comparing the optical rotationdata with those reported in the literature (Wang et al., 2008; Kang et al,, 2010; Lee et al, 2011).a'Conversion was determinedby H NMR analysis.bee was determined By chiral high-performance liquid chromatography analysis.1.10 mol/% catalyst loading.",
    "Table 2. Screening Solvents for Ni-Catalyzed Asymmetric Hydrogenation of 4-Phenyl-5H-1,2,3-oxathiazole2,2-dioxide (1a)NR, no reaction; NA, not available.Unless otherwise noted, all reactions were carried out with a NI(OAC)2/S, S-Ph-BPE/substrate la (0.1 mmol) ratio of 1:1:1.100in 1.0 mL solvent under 60 atm H2 at 80\u2103 for 24 h; the catalyst was pre-complexed in MeOH (0,1 mL for each reaction via).Conversion was determined by H NMR analysis.bee wasetermined by chiral high-performance liquid chromatography analysis.",
    "Table 3. Substrate Scope Study for Ni-Catalyzed Asymmetric Hydrogenation of Cyclic Sulfamidate IminesUnless otherwise noted, all reactions were carried out with a N(OAC2)/S, S-Ph-BPE/substrate 1.0.1 mmol/ratio of 1:11:100in1.0 mL CF-CH2OH under 60 atm H, at 80\u2103 for 24h. Conversion was determined by HNNR analysis. Yield is isolated yield.The ee value wasetermined by high-performance liquid chromatography on a chiral column.Superscript letter a indicates SC = 20.36h.",
    "Tegre S1O1, S1L, HPLC Spectrum of Raceme 5, selected to Scheme 4"
]